Financial News
Latest News about MRK
Recent news which mentions MRK
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
From Benzinga
From Benzinga
Market Rollercoaster Continues in Wake of Powell's Comments
December 01, 2021
From Benzinga
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
December 01, 2021
From Motley Fool
U.S. to tighten testing requirements for travelers in light of omicron variant, and analysts expected limited authorization of Merck antiviral
December 01, 2021
From MarketWatch
After high hopes for Merck’s COVID-19 pill, Wall Street now expects a ‘tepid’ authorization
December 01, 2021
From MarketWatch
Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In Kids
December 01, 2021
Tickers
MRK
From Benzinga
From Benzinga
AdComm Narrowly Backs Merck's COVID-19 Pill, Despite Efficacy Questions
December 01, 2021
From Benzinga
From MarketWatch
WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking
November 30, 2021
From MarketWatch
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
From Benzinga
Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors
November 30, 2021
From Benzinga
From Benzinga
Why Merck Stock Is Slipping Today
November 29, 2021
From Motley Fool
Merck stock dives after Citi downgrades on ‘high probability’ that HIV treatment will be abandoned
November 29, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
November 29, 2021
From Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
November 29, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
November 29, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
November 28, 2021
From Benzinga
Who Would Be the Best FDA Commissioner for Biotech Investors?
November 28, 2021
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30%
November 26, 2021
Tickers
MRK
From Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
November 24, 2021
From Benzinga
Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer
November 23, 2021
Tickers
MRK
From Benzinga
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
November 23, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
